genmab genmab-acquire-profoundbio-and-its-pipeline-next-generation - SERP Analysis

https://ir.genmab.com/news-releases/news-release-details/genmab-completes-acquisition-profoundbio

https://ir.genmab.com/news-releases/news-release-details/genmab-broaden-and-strengthen-oncology-portfolio-acquisition

https://www.biospace.com/genmab-leans-into-hot-adc-space-with-1-8b-profoundbio-acquisition

https://www.globenewswire.com/news-release/2024/04/03/2856591/0/en/Genmab-to-Broaden-and-Strengthen-Oncology-Portfolio-with-Acquisition-of-ProfoundBio.html

https://www.pharmaceutical-technology.com/news/genmab-acquires-profoundbio/

https://www.biopharminternational.com/view/genmab-to-acquire-profoundbio-in-1-8-billion-deal-gains-adc-pipeline

https://synapse.patsnap.com/article/genmab-acquires-profoundbio

https://www.medthority.com/news/2024/4/genmab-as-to-acquire-profoundbio-and-with-itrina-s-an-fralpha-adc-to-treat-ovarian-cancer/

https://chemanager-online.com/en/news/genmab-to-acquire-profoundbio-for-1-8-billion

https://www.globenewswire.com/news-release/2024/05/21/2885823/0/en/Genmab-Completes-Acquisition-of-ProfoundBio.html

https://www.investopedia.com/genmab-buys-profoundbio-for-usd1-8b-to-boost-oncology-portfolio-8624021

https://www.wsj.com/tech/biotech/genmab-strengthens-oncology-portfolio-with-1-8-bln-acquisition-of-profoundbio-b121c371?gaa_at=eafs&gaa_n=ASWzDAhhuakrLO6s_sqoT946C9RJQrQ1ssYwoHgR4NX_mVHplPUGq-_ua3h_&gaa_ts=6852b90d&gaa_sig=9PejlG9uRpXyeLRD2-qyTxDWN-0BvUthWTJeVoCjSqs6QAFA1qVwKIY-ZeCYN6NkLGo53xYVQNGsSXIxQPGbtw%3D%3D

https://www.contractpharma.com/breaking-news/genmab-to-acquire-profoundbio-for-18b/

https://www.worldpharmaceuticals.net/news/genmab-wraps-up-1-8bn-acquisition-of-adc-developer-profoundbio/

https://www.bioprocessintl.com/deal-making/genmab-bolsters-adc-portfolio-through-1-8bn-profoundbio-buy

https://european-biotechnology.com/latest-news/genmab-broadens-adc-pipeline-with-1-8bn-acquisition-of-profoundbio/

https://ir.genmab.com/news-releases/news-release-details/genmab-vigorously-defend-alleged-claims-trade-secret

https://chemanager-online.com/en/news/genmab-completes-acquisition-of-profoundbio

https://www.fiercebiotech.com/biotech/genmab-inks-18b-profoundbio-buyout-would-be-elahere-rival-teeing-scrap-adc-market

https://www.biopharmaboardroom.com/news/22/1746/genmab-to-acquire-profoundbio-for-usd-1-8-billion-in-cash.html

https://www.oncologypipeline.com/apexonco/profoundbio-takeout-shines-light-sutro

https://www.pharmaceutical-technology.com/news/genmab-joins-adc-arena-with-1-8bn-profoundbio-acquisition/

https://medcitynews.com/2024/04/genmab-adds-more-adc-firepower-with-1-8b-profoundbio-acquisition/

https://www.bioworld.com/articles/707248-in-first-major-m-and-a-genmab-adding-profoundbio-for-18b

https://www.healthcaremea.com/genmab-completes-us1-8b-profoundbio-acquisition-for-cancer-treatment-enhancement/

https://pharma.nridigital.com/pharma_jul24/latest_news

https://www.biopharmadive.com/news/genmab-profoundbio-adc-acquisition-buyout-seagen/712097/

https://www.streetinsider.com/Corporate%2BNews/Genmab%2BAS%2B%28GMAB%29%2Bto%2BAcquire%2BProfoundBio%2Bfor%2B%241.8B%2BCash/23018875.html

https://ir.genmab.com/node/47466/html

https://www.linkedin.com/posts/andrewwlam_genmab-completes-acquisition-of-profoundbio-activity-7198705096057049090-ZXWk

https://www.thepharmaletter.com/biotechnology/genmab-delves-further-into-adc-race-with-profoundbio-buy

https://ir.genmab.com/static-files/51870336-b7c8-4f4d-b030-aef00d17093f

https://www.fiercebiotech.com/biotech/after-profoundbio-buy-genmab-open-further-ma-make-strategic-sense-says-cfo

https://ir.genmab.com/static-files/4c3d4717-0fad-4b82-a7e4-e30f59bed25c

https://simplywall.st/community/narratives/dk/pharmaceuticals-biotech/cph-gmab/genmab-shares/epkinlys-global-approvals-and-profound-bio-acquisition-will-strengthen-future-oncology-pipeline

https://www.reuters.com/markets/deals/denmarks-genmab-acquire-profoundbio-18-billion-2024-04-03/

https://www.europeanpharmaceuticalreview.com/news/225396/adc-oncology-acquisition-to-address-solid-tumours/

https://www.biospace.com/employer/2810156/profoundbio

https://www.delveinsight.com/blog/pharma-news-for-astrazeneca-daiichi-sankyo-basilea-genmab

https://www.linkedin.com/posts/janvandewinkel_how-genmabs-first-acquisition-empowers-its-activity-7198729521645109248-GseS

https://firstwordpharma.com/story/5883798

https://m2pharma.co.uk/news/policy-and-regulations/article.php?id=103373

https://www.oncologypipeline.com/apexonco/genmab-formalises-challenge-against-its-partner

https://firstwordpharma.com/story/5934689

https://www.simmons-simmons.com/en/about-us/news/clurqnzlb00bwuatc40pkezbc/simmons-simmons-advises-in-genmab-s-acquisition-of-profoundbio

https://www.inderes.dk/en/releases/genmab-updates-2024-financial-guidance

https://www.genmab.com/

https://www.geneonline.com/antibody-drug-conjugates-connecting-drugs-to-cancer-cells-and-unlocking-billions-in-market-opportunities/

https://tools.morningstar.de/de/stockreport/newsItem.aspx?id=NASDAQ_1000952038-en

https://www.stockinsights.ai/us/GMAB/earnings-transcript/fy24-q4-1318

https://via.ritzau.dk/pressemeddelelse/14262991/genmab-as?publisherId=90446&lang=en

https://european-biotechnology.com/tag/genmab/

https://www.pharmiweb.com/press-release/2025-02-13/genmab-publishes-2024-annual-report

https://www.roic.ai/quote/GMAB.CO/transcripts/2024/4

https://insights.citeline.com/companies/genmab-as/

https://seekingalpha.com/article/4684021-genmab-acquires-a-missing-piece-for-its-pipeline

https://mfn.se/one/a/genmab/genmab-to-broaden-and-strengthen-oncology-portfolio-with-acquisition-of-profoundbio-d8ab9489

https://tools.morningstar.de/de/stockreport/newsItem.aspx?id=TDJNPR_202408082728

https://www.poandpo.com/companies/genmab-to-acquire-seattle-company-profoundbio-in-18b-deal/

https://www.decibio.com/insights/next-generation-therapeutics-march-round-up-2025

https://regnskaber.cvrapi.dk/xhtml/48832012/amNsb3VkczovLzAzLzM5L2M4LzllLzc3L2NhODktNDY3NS05ODExLWJlNDMxZTUxMGYzMA.pdf

https://www.insidermonkey.com/blog/genmab-a-s-gmab-among-12-high-growth-large-cap-stocks-to-buy-now-1391464/

https://www.publicnow.com/view/B43104CBAD63E41C906EF55D67988D6639BBC41A?1739378873

https://academic.oup.com/proteincell/advance-article/doi/10.1093/procel/pwaf002/7954518?searchresult=1

https://simplywall.st/community/narratives/dk/pharmaceuticals-biotech/cph-gmab/genmab-shares/late-stage-investments-in-epkinly-rina-s-and-acasunlimab-will-expand-market-potential

https://venturecapital.com/news/m-a/genmab-as-to-acquire-profoundbio-inc-for-usd-18-billion-in-cash-v1

https://pharmaboardroom.com/articles/asia-healthcare-weekly-31st-march-2025/

https://www.dimabio.com/blog/popular-targets-in-the-bispecific-adc-pipeline

https://www.businesswire.com/news/home/20250310558893/en/Genmab-Announces-Johnson-Johnson-Decision-Regarding-HexaBody-CD38

https://ir.genmab.com/static-files/193bf0f2-b7d2-4198-862f-43126a25fd3e

https://synapse.patsnap.com/drug/8e87dfc5d2ce4807a57cfc5ef17d618c

https://www.zoominfo.com/c/genmab-as/15827243

https://www.citeline.com/-/media/BC80E9D6565E4100B8B9E20A3A9980B4

https://www.kron4.com/business/press-releases/globenewswire/1000932683/genmab-to-broaden-and-strengthen-oncology-portfolio-with-acquisition-of-profoundbio

https://ir.genmab.com/static-files/e17c16da-89cb-4e68-a34e-9222da5e4098

https://en.wikipedia.org/wiki/Genmab

https://medicalbuyer.co.in/genmab-to-strengthen-oncology-portfolio-with-profoundbio-acquisition/

https://hub-xchange.com/news-xchange-articles/adc-landscape-flux-layoffs-setbacks-legal-battles-new-clinical-advances

https://www.life-sciences-asia.com/news/abbvie-files-complaint-against-profoundbio-genmab-group-inc-2001-124118.html

https://www.finanznachrichten.de/nachrichten-2024-04/61846968-genmab-a-s-genmab-to-broaden-and-strengthen-oncology-portfolio-with-acquisition-of-profoundbio-004.htm

https://xtalks.com/genmabs-silver-anniversary-reflecting-on-25-years-of-breakthroughs-in-antibody-therapeutics-3818/

https://delta.larvol.com/Products/?ProductId=51dc6ddc-4ae7-4cee-8931-ad7b996cd148

https://seekingalpha.com/article/4788097-genmab-as-transitioning-from-royalty-model-to-commercial-stage-oncology

https://pharmashots.com/18611/enhancing-capabilities-tahi-ahmadi-from-genmab-in-a-riveting-dialogue-exchange-with-pharmashots/

https://www.nasdaq.com/press-release/genmab-vigorously-defend-alleged-claims-trade-secret-misappropriation-abbvie-inc-2025

https://www.pharmavoice.com/news/adc-daiichi-genmab-sutro-tubulis-merck-immunogen/720125/

https://lifesciencewa.org/2024/04/08/biotech-giant-genmab-to-acquire-seattle-company-and-lsw-institute-win-graduate-profound-bio-in-1-8b-deal/

https://ir.genmab.com/news-releases/news-release-details/genmab-publishes-2024-annual-report

https://www.investseekers.com/post/genmab-a-strong-contender-in-the-biopharma-market

https://pharma.nridigital.com/pharma_may24/latest_news

https://www.caproasia.com/2024/04/12/19-billion-denmark-biotech-giant-genmab-buys-clinical-cancer-treatment-specialist-profoundbio-for-1-8-billion-in-all-cash-deal/

https://finance.yahoo.com/news/genmab-gmab-q3-2024-earnings-072009368.html

https://www.investing.com/news/company-news/rbc-capital-upgrades-genmab-stock-amid-strong-pipeline-prospects-93CH-3518514

https://money.tmx.com/quote/GMAB:US/news/6174234597860423/Genmab_Announces_Financial_Results_for_the_First_Quarter_of_2024

https://ir.genmab.com/static-files/9babf34b-bff3-40c7-a14c-29214f4f393a

https://medcitynews.com/2025/06/asco-2025-cancer-bispecific-antibody-drug-conjugate-adc-degraders-oncology/

https://www.tipranks.com/news/company-announcements/genmab-expands-oncology-reach-with-profoundbio-buyout

https://ugebrev.dk/flashnews/transcript-fra-genmab-investormoede-efter-aarsregnskab-2024-incl-qa/

https://in.investing.com/news/earnings-call-genmab-reports-strong-q1-growth-plans-profoundbio-acquisition-93CH-4165279